Your browser doesn't support javascript.
loading
Dasatinib overcomes glucocorticoid resistance in B-cell acute lymphoblastic leukemia.
Sarno, Jolanda; Domizi, Pablo; Liu, Yuxuan; Merchant, Milton; Pedersen, Christina Bligaard; Jedoui, Dorra; Jager, Astraea; Nolan, Garry P; Gaipa, Giuseppe; Bendall, Sean C; Bava, Felice-Alessio; Davis, Kara L.
Afiliação
  • Sarno J; Hematology, Oncology, Stem Cell Transplant, and Regenerative Medicine, Department of Pediatrics, Stanford University, Stanford, CA, USA. jolanda@stanford.edu.
  • Domizi P; Hematology, Oncology, Stem Cell Transplant, and Regenerative Medicine, Department of Pediatrics, Stanford University, Stanford, CA, USA.
  • Liu Y; Hematology, Oncology, Stem Cell Transplant, and Regenerative Medicine, Department of Pediatrics, Stanford University, Stanford, CA, USA.
  • Merchant M; Hematology, Oncology, Stem Cell Transplant, and Regenerative Medicine, Department of Pediatrics, Stanford University, Stanford, CA, USA.
  • Pedersen CB; Section for Bioinformatics, Department of Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark.
  • Jedoui D; Hematology, Oncology, Stem Cell Transplant, and Regenerative Medicine, Department of Pediatrics, Stanford University, Stanford, CA, USA.
  • Jager A; Hematology, Oncology, Stem Cell Transplant, and Regenerative Medicine, Department of Pediatrics, Stanford University, Stanford, CA, USA.
  • Nolan GP; Department of Pathology, Stanford University, Stanford, CA, USA.
  • Gaipa G; M. Tettamanti Research Center, Fondazione IRCCS San Gerardo dei Tintori, Monza, (MB), Italy.
  • Bendall SC; Department of Pathology, Stanford University, Stanford, CA, USA.
  • Bava FA; Baxter Laboratory, Department of Microbiology and Immunology, Stanford University, Stanford, CA, USA.
  • Davis KL; Institut national de la santé et de la recherche médicale (INSERM), Paris, France.
Nat Commun ; 14(1): 2935, 2023 05 22.
Article em En | MEDLINE | ID: mdl-37217509

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras B / Linfoma de Burkitt Limite: Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras B / Linfoma de Burkitt Limite: Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
...